POSIMIR (Bupivacaine Solution) 660 mg/5mL (132 mg/mL)

POSIMIR by

Drug Labeling and Warnings

POSIMIR by is a Prescription medication manufactured, distributed, or labeled by Renaissance Lakewood, LLC. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

POSIMIR- bupivacaine injection 
Renaissance Lakewood, LLC

----------

POSIMIR (Bupivacaine Solution) 660 mg/5mL (132 mg/mL)

Product Label

Product Image - Boxed Warning

Product Vial

Product Vial Product Carton

Product Image - Posimir

POSIMIR 
bupivacaine injection
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC: 49396-6601
Route of AdministrationINFILTRATION
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
BUPIVACAINE (UNII: Y8335394RO) (BUPIVACAINE - UNII:Y8335394RO) BUPIVACAINE660 mg  in 5 mL
Inactive Ingredients
Ingredient NameStrength
BENZYL ALCOHOL (UNII: LKG8494WBH)  
SUCROSE ACETATE ISOBUTYRATE (UNII: H5KI1C3YTV)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC: 49396-6601-010 in 1 CARTON05/31/2022
15 mL in 1 BOTTLE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
NDANDA20480305/31/202208/02/2024
Labeler - Renaissance Lakewood, LLC (077744035)
Registrant - Renaissance Lakewood, LLC (077744035)

Revised: 10/2024
Document Id: 2474c73d-640a-16a7-e063-6394a90af357
Set id: efb90d91-f984-294d-e053-2a95a90ad3c4
Version: 2
Effective Time: 20241014
 

Trademark Results [POSIMIR]

Mark Image

Registration | Serial
Company
Trademark
Application Date
POSIMIR
POSIMIR
85785555 4918452 Live/Registered
DURECT CORPORATION
2012-11-21
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.